GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Enterprises Ltd (BOM:543444) » Definitions » Revenue

Fabino Enterprises (BOM:543444) Revenue : ₹124.7 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Fabino Enterprises Revenue?

Fabino Enterprises's revenue for the six months ended in Sep. 2024 was ₹42.5 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ₹124.7 Mil. Fabino Enterprises's Revenue per Share for the six months ended in Sep. 2024 was ₹19.81. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₹58.87.

Warning Sign:

Fabino Enterprises Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Fabino Enterprises was -19.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 90.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 25.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 6 years, Fabino Enterprises's highest 3-Year average Revenue per Share Growth Rate was 90.30% per year. The lowest was -23.50% per year. And the median was 15.00% per year.


Fabino Enterprises Revenue Historical Data

The historical data trend for Fabino Enterprises's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fabino Enterprises Revenue Chart

Fabino Enterprises Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Revenue
Get a 7-Day Free Trial 75.16 30.58 42.01 33.60 210.83

Fabino Enterprises Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only 10.42 23.18 128.61 82.22 42.51

Competitive Comparison of Fabino Enterprises's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Enterprises's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fabino Enterprises's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fabino Enterprises's Revenue distribution charts can be found below:

* The bar in red indicates where Fabino Enterprises's Revenue falls into.


;
;

Fabino Enterprises Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹124.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fabino Enterprises  (BOM:543444) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Fabino Enterprises Revenue Related Terms

Thank you for viewing the detailed overview of Fabino Enterprises's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Fabino Enterprises Business Description

Traded in Other Exchanges
N/A
Address
Murthal Road, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001
Fabino Enterprises Ltd formerly known as Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.

Fabino Enterprises Headlines

No Headlines